EBF1-mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the P53 Signaling Pathway

Cancer Research - United States
doi 10.1158/0008-5472.can-18-3238
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Upregulation of Acetylcholinesterase Mediated by P53 Contributes to Cisplatin-Induced Apoptosis in Human Breast Cancer Cell

Journal of Cancer
Oncology
2015English

PHD3 Affects Gastric Cancer Progression by Negatively Regulating HIF1A

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

ASIC1 Promotes Differentiation of Neuroblastoma by Negatively Regulating Notch Signaling Pathway

Oncotarget
Oncology
2016English

microRNA-16 Represses Colorectal Cancer Cell Growth in Vitro by Regulating the P53/Survivin Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2013English

The Tumor Suppressor, P53, Contributes to Radiosensitivity of Lung Cancer Cells by Regulating Autophagy and Apoptosis

Cancer Biotherapy and Radiopharmaceuticals
Nuclear MedicineRadiologyPharmacologyCancer ResearchOncologyImagingMedicine
2013English

TopBP1 Contributes to the Chemoresistance in Non-Small Cell Lung Cancer Through Upregulation of P53

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

CARD10 Promotes the Progression of Renal Cell Carcinoma by Regulating the NF‑κB Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

PAR2-Mediated Upregulation of BDNF Contributes to Central Sensitization in Bone Cancer Pain

Molecular Pain
Molecular MedicineAnesthesiologyPain MedicineCellularMolecular Neuroscience
2014English

The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression

PLoS ONE
Multidisciplinary
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy